{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:41Z","timestamp":1784408861124,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01016-y","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:08:00Z","timestamp":1751274480000},"page":"751-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early low-density lipoprotein apheresis for steroid-resistant minimal change disease with acute kidney injury: a case report"],"prefix":"10.1007","volume":"14","author":[{"given":"Miya","family":"Hiramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-0422","authenticated-orcid":false,"given":"Masatoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kamegai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohno","family":"Michiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"3","key":"1016_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10157-014-1022-x","volume":"19","author":"H Yokoyama","year":"2015","unstructured":"Yokoyama H, et al. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan renal biopsy registry (J-RBR). Clin Exp Nephrol. 2015;19(3):496\u2013505.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"1016_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94(5):861\u20139.","journal-title":"Kidney Int"},{"issue":"3","key":"1016_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1016_CR4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468\u201374.","journal-title":"Kidney Int"},{"issue":"10","key":"1016_CR5","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00467-018-4061-9","volume":"34","author":"R Raina","year":"2019","unstructured":"Raina R, et al. An update on LDL apheresis for nephrotic syndrome. Pediatr Nephrol. 2019;34(10):1655\u201369.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1016_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10157-013-0930-5","volume":"18","author":"E Muso","year":"2014","unstructured":"Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol. 2014;18(2):286\u201390.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"1016_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/ki.1984.76","volume":"25","author":"SO Bohman","year":"1984","unstructured":"Bohman SO, et al. Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome. Kidney Int. 1984;25(4):696\u2013700.","journal-title":"Kidney Int"},{"issue":"3","key":"1016_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MNH.0b013e3282f88a1f","volume":"17","author":"GS Hill","year":"2008","unstructured":"Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17(3):266\u201370.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"1016_CR9","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1093\/ndt\/gfu366","volume":"30","author":"A Meyrier","year":"2015","unstructured":"Meyrier A. Nephrosclerosis: update on a centenarian. Nephrol Dial Transpl. 2015;30(11):1833\u201341.","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl 1","key":"1016_CR10","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1097\/00005344-199800001-00138","volume":"31","author":"SC Wolf","year":"1998","unstructured":"Wolf SC, et al. Endothelin-1 and endothelin-3 levels in different types of glomerulonephritis. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S482\u20135.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1016_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000328720","volume":"172","author":"Z Guan","year":"2011","unstructured":"Guan Z, Inscho EW. Endothelin and the renal vasculature. Contrib Nephrol. 2011;172:35\u201349.","journal-title":"Contrib Nephrol"},{"issue":"5","key":"1016_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.ajkd.2005.02.007","volume":"45","author":"CL Chen","year":"2005","unstructured":"Chen CL, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis. 2005;45(5):818\u201325.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1016_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1056-8727(02)00171-X","volume":"17","author":"T Nakamura","year":"2003","unstructured":"Nakamura T, et al. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. J Diabetes Complic. 2003;17(6):349\u201354.","journal-title":"J Diabetes Complic"},{"issue":"3","key":"1016_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10157-014-0996-8","volume":"19","author":"E Muso","year":"2015","unstructured":"Muso E, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS study. Clin Exp Nephrol. 2015;19(3):379\u201386.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"1016_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000437338","volume":"5","author":"E Muso","year":"2015","unstructured":"Muso E, et al. A Prospective observational survey on the long-term effect of ldl apheresis on drug-resistant nephrotic syndrome. Nephron Extr. 2015;5(2):58\u201366.","journal-title":"Nephron Extr"},{"issue":"1","key":"1016_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1744-9987.13694","volume":"26","author":"E Muso","year":"2022","unstructured":"Muso E, et al. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function. Ther Apher Dial. 2022;26(1):220\u20138.","journal-title":"Ther Apher Dial"},{"issue":"4","key":"1016_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0272-6386(12)80007-2","volume":"16","author":"JV Donadio Jr","year":"1990","unstructured":"Donadio JV Jr. Treatment of glomerulonephritis in the elderly. Am J Kidney Dis. 1990;16(4):307\u201311.","journal-title":"Am J Kidney Dis"},{"issue":"8311","key":"1016_CR18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309\u201311.","journal-title":"Lancet"},{"issue":"6","key":"1016_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/1744-9987.14056","volume":"27","author":"E Muso","year":"2023","unstructured":"Muso E, et al. Updated evidence of beneficial effect of LDL apheresis for refractory nephrotic syndrome due to a variety of causative diseases for nationwide and global approval. Ther Apher Dial. 2023;27(6):987\u201399.","journal-title":"Ther Apher Dial"},{"key":"1016_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.atherosclerosissup.2015.02.013","volume":"18","author":"F Heigl","year":"2015","unstructured":"Heigl F, et al. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany. Atheroscler Suppl. 2015;18:154\u201362.","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"1016_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10157-007-0003-8","volume":"12","author":"S Kobayashi","year":"2008","unstructured":"Kobayashi S. Applications of LDL-apheresis in nephrology. Clin Exp Nephrol. 2008;12(1):9\u201315.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"1016_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.diabres.2014.08.012","volume":"106","author":"E Sato","year":"2014","unstructured":"Sato E, et al. LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis. Diabetes Res Clin Pract. 2014;106(2):241\u20136.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1016_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/nep.13120","volume":"23","author":"S Nakatani","year":"2018","unstructured":"Nakatani S, et al. The efficacy of low-density lipoprotein apheresis in a patient with drug-resistant minimal change nephrotic syndrome: a case report and a review of the literature. Nephrology (Carlton). 2018;23(6):603\u20134.","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"1016_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12882-020-02071-6","volume":"21","author":"R Nishizono","year":"2020","unstructured":"Nishizono R, et al. Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report. BMC Nephrol. 2020;21(1):410.","journal-title":"BMC Nephrol"},{"key":"1016_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/IJNRD.S248610","volume":"13","author":"K Terada","year":"2020","unstructured":"Terada K, et al. Low-density lipoprotein apheresis in patients with acute kidney injury due to minimal change disease requiring acute renal replacement therapy. Int J Nephrol Renovasc Dis. 2020;13:157\u201362.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"3","key":"1016_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/1744-9987.12561","volume":"21","author":"H Suzuki","year":"2017","unstructured":"Suzuki H, et al. Rituximab-resistant nephrotic syndrome with successful induction of remission by low-density lipoprotein apheresis. Ther Apher Dial. 2017;21(3):295\u20136.","journal-title":"Ther Apher Dial"},{"issue":"5","key":"1016_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","volume":"69","author":"RJ Maas","year":"2017","unstructured":"Maas RJ, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis. 2017;69(5):637\u201346.","journal-title":"Am J Kidney Dis"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:13:33Z","timestamp":1758719613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01016-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from the individual participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent for publication"}}]}}